Kintara Therapeutics, Inc. Insider Trading for July 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kintara Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kintara Therapeutics, Inc. for July 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Zarrabian Saiid | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 11 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Option Exercise | A | 2.11 | 36,000 | 75,960 | 36,000 | |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | TOTH ROBERT JOSEPH JR | Director | Buy | J | 3.20 | 74 | 237 | 11,221 | 11.1 K to 11.2 K (+0.66 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 29,655 | 29.4 K to 29.7 K (+0.72 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Mohr Erich | Director | Buy | J | 3.20 | 528 | 1,690 | 6,638 | 6.1 K to 6.6 K (+8.64 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Cranston Lynda Sarah | Director | Buy | J | 3.20 | 71 | 227 | 2,415 | 2.3 K to 2.4 K (+3.03 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Brown Dennis M | Chief Scientific Of ... | Buy | J | 3.20 | 169 | 541 | 885,177 | 885 K to 885.2 K (+0.02 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Bell John K | Director | Buy | J | 3.20 | 282 | 902 | 49,737 | 49.5 K to 49.7 K (+0.57 %) |
| Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | BACHA JEFFREY | CEO | Buy | J | 3.20 | 176 | 563 | 53,521 | 53.3 K to 53.5 K (+0.33 %) |